Whyteman’s Brae Hospital

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome

Katherine James, Shereen Al-Ali, Jessica Tarn et al. · PLoS ONE · 2015 · 176 citations · Full text

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)

Ariane L. Herrick, Xiaoyan Pan, Sébastien Peytrignet et al. · Annals of the Rheumatic Diseases · 2017 · 134 citations · Full text

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial

Duncan Porter, Jurgen van Melckebeke, James Dale et al. · The Lancet · 2016 · 118 citations · Full text

Inflammation, Rheumatology, Biological Treatment +11

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

Dennis Lendrem, Sheryl Mitchell, Peter McMeekin et al. · Annals of the Rheumatic Diseases · 2013 · 110 citations

Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)

Federica Maritati, Roberta Fenoglio, Évangéline Pillebout et al. · Arthritis & Rheumatology · 2017 · 94 citations · Full text